also demonstrated in triple-negative breast cancer that PSMB5 is an indicator of poor prognosis and the silencing of the PSMB5 gene can increase the sensitivity of breast cancer cells to chemotherapy and subsequently to apoptosis (61). This evidence concerns the gene PSMB5 and breast cancer.